The randomized, double-blind, sham-controlled trial evaluated 56 adults with ADHD who received four weeks of Nexalin’s ...

A 150-child trial found an FDA-cleared ADHD stimulation device did not significantly reduce symptoms, raising concerns over ...

Paroxysmal sympathetic hyperactivity (PSH) is a critical yet under‐recognised complication following acute brain injuries, particularly traumatic brain injury (TBI) and encephalitis. It manifests as ...

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key brain cells, restoring vital dopamine communication and neuroprotective ...

Successfully treating type 2 diabetes may involve focusing on brain neurons, rather than simply concentrating on obesity or insulin resistance, according to a new study. For several years, researchers ...

Attention-deficit/hyperactivity disorder (ADHD) is primarily known for its inattentive, hyperactive, and impulsive symptoms. However, recent research and lived ...